Summary of Acid reducing medications
Transcript for Acid reducing medications
Acid reducing medications
Acid reducing medications include antacids that directly lower the acidity of stomach contents, and antisecretory medications that act on parietal cells in the stomach to decrease acid secretion.
Now, the stomach is composed of four regions: the cardia, the fundus, the body, and the pyloric antrum. There’s also a pyloric sphincter, or valve, at the end of the stomach, which closes while eating, keeping food inside for the stomach to digest.
The epithelial layer of the stomach contains a variety of gastric glands which secrete a variety of substances.
Starting with the cardia, it contains mostly foveolar cells that secrete a protective mucus, which is mostly made up of water and glycoproteins.
The fundus and the body contain both the parietal cells and enterochromaffin-like cells, and the antrum and pyloric areas contain G-cells.
Now gastric acid is mainly composed of HCl, or hydrochloric acid, which is mainly secreted by the parietal cells.
Parietal cells have M3, CCK2, and H2 membrane receptors, which modulate its secretory behavior. When food enters the stomach, it causes the stomach walls to expand, which leads to the activation of these receptors.
First, stomach expansion causes the branches of the vagus nerve that innervates the stomach to release acetylcholine, which activates M3 receptors.
Next, the G cells in the antrum of the stomach release gastrin, which active the CCK2 receptors.
Gastrin and acetylcholine activate the enterochromaffin-like cells, which release histamine, that activates H2 receptors.
Activation of M3, CCK2, and H2 receptors increases the conversion of H20 and CO2 to H+ and HCO3- by carbonic anhydrase.
The H+ is then pumped out of the cell and into the stomach via the H+/K+-ATPase pump. These H+ ions combine with Cl- ions to form hydrochloric acid and decrease the pH in the stomach.
Normally, the stomach is protected from the acidic environment by the mucus secreted by foveolar cells. However, if there’s an imbalance between mucus and acid secretion, like in Zollinger-Ellison syndrome, which is caused by a gastrin secreting tumor, it could lead to damage of the stomach. This could manifest as chronic gastritis and gastric, or peptic ulcers.
Now, in the esophagus, the lower esophageal sphincter prevents most of the gastric acid from coming back up when the stomach is full or when you’re laying down. If this sphincter is loose, the acid could reflux into the lower esophagus and erode the esophageal lining. This is called GERD, or gastroesophageal reflux disease, more commonly known as heartburn.
One way to mitigate the harmful effects of gastric acid in these disorders is to decrease its acidity through medications.
Let’s start with the H2 receptor antagonists like cimetidine, ranitidine, and famotidine.
These medications competitively inhibit H2 receptors, meaning they bind to these receptors so histamine can’t.
These drugs are able to decrease night time and food stimulated acid secretion by over 90%.
They generally take effect within an hour of ingestion and lasts for around 12 hours, so they are perfect for taking before bedtime.
They are generally given orally, but intramuscular and IV formulations are available.
Now, cimetidine is a strong inhibitor of cytochrome P450 enzymes in the liver. These enzymes are responsible for the metabolism of a variety of drugs and toxins in our body. So, if taken with other medications like benzodiazepines or warfarin, cimetidine could reduce the rate of elimination of these other drugs and cause them to build up in the body.
Cimetidine also has anti-androgenic effects and could cause gynecomastia, sexual dysfunctions like decreased libido, and loss of hair, or alopecia. Since it crosses the blood brain barrier, it could also cause confusion and dizziness.
Next we have the proton pump inhibitors, or PPIs, which include oral medications like omeprazole, lansoprazole, dexlansoprazole, and medications available in IV, like pantoprazole and esomeprazole.
The oral forms of these medications are absorbed in the small intestine in their inactive form and get metabolized in the liver.
Next they travel through the blood to the parietal cells where the acidic environment help protonate them so they become fully active.
These activated PPIs irreversibly bind to and inhibit the H+/K+-ATPase, or proton pumps, found within parietal cells.